Anji Pharmaceuticals
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines in China and worldwide.
Industries
pharmaceutical
Nr. of Employees
small (1-50)
Patents
Products
ANJ900
A gut-targeted formulation of metformin designed for type 2 diabetes patients with advanced chronic kidney disease, aiming to lower glucose with reduced systemic exposure.
ANJ908 (Pradigastat)
A DGAT1 inhibitor for treating chronic idiopathic constipation, focusing on increasing bowel movement frequency and softer stool by changing the intestinal milieu.
ANJ900
A gut-targeted formulation of metformin designed for type 2 diabetes patients with advanced chronic kidney disease, aiming to lower glucose with reduced systemic exposure.
ANJ908 (Pradigastat)
A DGAT1 inhibitor for treating chronic idiopathic constipation, focusing on increasing bowel movement frequency and softer stool by changing the intestinal milieu.